CD276 and neoplasm: B7 homolog 3 protein (also known as CD276) is a member of the B7 family overexpressed in tumor tissues and is a costimulatory/coinhibitory immunoregulatory protein that performs a dual role in the immune system during T-cell activation and is an emerging target for antibody-based immunotherapy [55].